BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu RS, Liao WJ, Ma JS, Wang JK, Wu LQ, Hou P. Epidemiology and outcome of individuals with intraductal papillary neoplasms of the bile duct. World J Gastrointest Oncol 2023; 15(5): 843-858 [PMID: 37275447 DOI: 10.4251/wjgo.v15.i5.843]
URL: https://www.wjgnet.com/1948-5204/full/v15/i5/843.htm
Number Citing Articles
1
Xia-hui Huang, Tian-xiang Chen, Hong-liang Liu, Ming-wen Huang. A Review of Type 1 and Type 2 Intraductal Papillary Neoplasms of the Bile DuctCurrent Medical Science 2024; 44(3): 485 doi: 10.1007/s11596-024-2863-5
2
Di Zeng, Bei Li, Nansheng Cheng. Prognostic factors for intraductal papillary neoplasm of the bile duct following surgical resection: a systematic review and meta-analysisSurgery Today 2024;  doi: 10.1007/s00595-024-02948-1
3
Efstathios T Pavlidis, Ioannis N Galanis, Theodoros E Pavlidis. Current considerations on intraductal papillary neoplasms of the bile duct and pancreatic ductWorld Journal of Gastroenterology 2024; 30(10): 1461-1465 doi: 10.3748/wjg.v30.i10.1461
4
Vor Luvira. Tri-modal death distribution towards personalized management of intraductal papillary neoplasm of the bile duct patients: Every story has its own conclusionHepatobiliary & Pancreatic Diseases International 2024; 23(3): 313 doi: 10.1016/j.hbpd.2024.01.004
5
Masumi Kawaguchi, Tomohiro Itonaga, Ryuji Mikami, Aoi Sukeda, Takayoshi Tsuchiya, Atsushi Sofuni, Takao Itoi, Kazuhiro Saito. A Case of High-Dose-Rate Brachytherapy Under Endoscopic Retrograde Cholangiopancreatography (ERCP) for Intraductal Papillary Neoplasm of the Bile DuctCureus 2024;  doi: 10.7759/cureus.58254